Blog

Current and future therapeutic demands of Paracetamol (Q2, 2019)

MedAnalytics

MedAnalytics defines market demand by measuring the quantity of a generic that required for clinical management for a given time period.It also speculates a market size within the therapeutic class and validates a plan of a product in business consideration based on current and potential market demand.In Q3, 2016 to Q2 2019, Paracetamol market demand increased at 14.7% CAGR. While demand for others changed: Ketorolac Tromethamine at 3% CAGR, Paracetamol + Caffeine at 4.23% CAGR, Paracetamol IV at 33.89% CAGR, Nefopam Hydrochloride at -12.64% CAGR and Metamizol at -14.06% CAGR.Over the forecast period of 2020 - 2022, Paracetamol market demand is expected to increase at 6.66% CAGR. While demand for others are expected to change: Ketorolac Tromethamine at 4.21% CAGR, Paracetamol + Caffeine at 3.69% CAGR, Paracetamol IV at 11.02% CAGR, Nefopam Hydrochloride at -100% CAGR and Metamizol at -18.54% CAGR.

You might be interested to our other reports

Get Registered for more details